RxDoctor Payments DataLook up a doctor →

Michael Reuter, DPM

Foot & Ankle Surgery · Bristol, RINPI 1124356365

Payments from drug & device makers

$34,420in general payments, 2019–2025

Across 386 payments — averaging $89.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$18K
  • Smith+Nephew$6K
  • Biotissue Holdings Inc.$2K
  • Stryker$2K
  • Treace Medical Concepts, Inc.$858
  • Zimmer Biomet$463
  • plus $5K from 46 others

What the payments were for

  • Speaking & faculty fees$16,66348%
  • Travel & lodging$3,72711%
  • Food & beverage$14,03041%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.36$18,464
Smith+Nephew144$5,877
Biotissue Holdings Inc.59$1,918
Stryker(2 entities)11$1,527
Treace Medical Concepts, Inc.6$858
Zimmer Biomet5$463
Integra Lifesciences Corporation11$461
Medtronic(2 entities)5$386
Polynovo North America LLC8$317
Acera Surgical, Inc.4$280
Paratek Pharmaceuticals, Inc.9$275
Orthofix Medical, Inc.6$253
Innovation Technologies Inc2$253
Acumed LLC3$229
Biocomposites Inc4$218
Melinta Therapeutics, LLC5$181
Hydrofera LLC5$172
Acell, Inc.2$170
Cardiovascular Systems Inc.1$167
Next Science LLC6$163
KCI USA, Inc.4$160
Derma Sciences, Inc.3$142
Amgen2$131
Kerecis Limited2$129
Bsn Medical Inc1$104
Biowound Solutions, Inc.1$102
Baxter Healthcare2$86
Tactile Systems Technology Inc1$84
Biedermann Motech, Inc.2$84
Osiris Therapeutics Inc.2$81
Bioventus LLC1$79
TELA Bio, Inc.3$62
Convatec Inc.3$55
Nevro Corp.2$51
GSK2$50
Solventum Corporation2$44
Ortho Dermatologics, A Division Of Bausch Health US, LLC3$40
Ulrich Medical USA, Inc.1$37
Medline Industries LP2$36
Averitas Pharma Inc.2$36
Bone Support Inc.1$30
Merck2$27
Mimedx Group, Inc.1$18
Novo Nordisk1$17
Nabriva Therapeutics, PLC1$15
Kowa Pharmaceuticals America, Inc.1$15
Novartis1$13
IBSA Pharma Inc.1$13
Pfizer1$13
Genentech USA, Inc.1$12
Misonix Inc1$11
Sebela Pharmaceuticals Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,420 in reported general payments places this provider in the 90th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island →

Medicare billing

Part B allowed, 2024
$273,463
Medicare patients
400
Services billed
3,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole16$329
Diclofenac Sodium12$183
Naproxen17$148
Cephalexin27$146

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Bristol

See the full list for Rhode Island →

Where these figures come from

Is this you, or does something look wrong? →